Search

everythinglearnresearchcommunity

for

Search:↓

Biomimetic nanovesicles can speed up diabetic wound healing by regulating immune cell behavior and metabolism.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Activating PKCα in skin causes cell death and inflammation through different pathways.

Topical dapsone may effectively treat lichen planopilaris in the beard, especially for those who can't tolerate standard treatments.

Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Higher inflammation markers are linked to more severe alopecia areata.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Severe acne patients have higher inflammatory markers than healthy people.

Higher inflammation markers are linked to more severe alopecia areata.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Blocking certain fat production can reverse skin inflammation and hair loss.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.